$WLKP

Friel Lisa A. sold (to issuer) $53K of WLKP

Friel Lisa A. sold (to issuer) 2,502 shares of Westlake Chemical Partners LP (WLKP) at $21.35 on 2026-08-06.

Original reporting
SEC EDGAR · Friel Lisa A.
Published Aug 7, 2026, 11:35 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 11:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$WLKP
Neutral
high confidence
Mentioned
$WLKP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WLKPNeutralLow
01

Why it matters

The only new information is the reported sale size, price, and post-transaction holdings; there is no guidance, earnings, or operational change described.

02

Market read

Traders may note insider selling activity, but the filing provides no fundamental change and is unlikely to drive material repricing.

03

What to watch

Code D (sale to issuer) often reflects administrative liquidity or buyback participation mechanics rather than a bearish view on the partnership’s outlook.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-07 pre-market window (07:35:35-04:00)

Background

The article is a SEC Form 4 insider transaction disclosure for a director of Westlake Chemical Partners LP.

Company-level read

Ticker impact

$WLKPNeutralHigh confidence
Context

Westlake Chemical Partners LP disclosed an insider sale to the issuer: 2,502 shares at $21.3500 on 2026-08-06, total $53,417.70.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4.

Evidence & confidence

The filing is a Form 4 insider sale to issuer under code D, with no 10b5-1 plan and no accompanying company-specific operational or financial update.

Market effects

Minimal. Insider sale-to-issuer filings typically do not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could prompt some traders to scrutinize insider behavior, but the transaction is small and lacks a fundamental catalyst.

Key entities

  • Westlake Chemical Partners LP

    Subject of the Form 4 insider transaction disclosure (WLKP).

  • Friel Lisa A.

    Director who sold 2,502 shares to the issuer at $21.3500 on 2026-08-06.

Related articles

$WLKPMed

Westlake Chemical Partners LP (WLKP): Results of Operations and Financial Condition

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_20260630earningsrele.htm EX-99.1 Document EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jonathan Baksht Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Second Quarter 2026 Results • Declared quarterly distribution

$WLKPMedAI 8/10

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (NYSE: WLKP) reported Q2 2026 net income attributable to the partnership of $14.2 million, or $0.40 per limited partner unit, versus $14.6 million in Q2 2025. Operating cash flow was $129.8 million. It declared a $0.4714 per unit distribution, 48th consecutive quarter, with trailing twelve-month coverage of 1.04x. Credit facilities were amended to extend maturities to July 2031.